$CL

Colgate-Palmolive reaffirms annual sales forecast on weak North America demand

Amazon shares rally as cloud growth surges and spending outlook climbs July 31 (Reuters) - Colgate-Palmolive on Friday reaffirmed its annual sales forecast even after posting a quarterly rise as the toothpaste maker continues to grapple with muted demand in North America, sending its shares down 2.5%. Higher food and fuel prices tied to the Middle East conflict have hit lower-income shoppers hard, making it harder for U.S.

Original reporting
Published Jul 31, 2026, 12:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 12:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CL
Bearish
medium confidence
Mentioned
$CL
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$CLBearishMed
01

Why it matters

The reaffirmed annual sales forecast reduces uncertainty on top-line growth, but the explicit warning that tariffs may more than offset refunds introduces a new risk factor for earnings expectations.

02

Market read

Traders get a fresh guidance reaffirmation plus a specific tariff headwind that can reprice earnings risk even without a cut to annual sales growth.

03

What to watch

The article notes inventory reductions at key retailers and volume declines; if retailer restocking reverses, the tariff impact may be less severe than implied.

Relevance 7/10Novelty 6/10Timing: today, post-earnings guidance reaffirmation and tariff warning

Background

Colgate-Palmolive is dealing with muted North America demand, including volume declines and market share pressure, while navigating tariff policy changes.

Company-level read

Ticker impact

$CLBearishMedium confidence
Context

Colgate-Palmolive reaffirmed its annual net sales growth outlook while warning new 10% and 12.5% tariffs could more than offset refunds.

Expected impact

Near-term bias to downside or higher volatility as traders weigh tariff risk against the reaffirmed sales and raised earnings base.

Evidence & confidence

The article’s incremental decision-relevant detail is the explicit tariff warning that could negate prior benefit from refunds, which can change expectations even without a guidance cut.

Market effects

Signals continued pressure on US consumer-goods demand and tariff sensitivity for packaged goods companies with North America exposure.

Highlights weaker North America organic sales tied to lower-income shopper strain.

Tariff changes tied to US policy can propagate across multinational consumer-goods supply chains and pricing strategies.

Counterpoint

The company raised the base of its 2026 adjusted earnings forecast to mid-single-digit growth, which could cushion the tariff narrative if demand stabilizes.

Key entities

  • Colgate-Palmolive

    Toothpaste and consumer goods company reaffirming annual sales forecast and warning tariffs may offset refunds.

  • Procter & Gamble

    Rival referenced for its slower fiscal 2027 revenue growth forecast in a challenging environment.

  • Trump administration

    Imposed new 10% and 12.5% tariffs referenced as a headwind to Colgate’s outlook.

Related articles

$CLMed

Colgate-Palmolive Reaffirms Sales Forecast On Weak Demand

Colgate-Palmolive reaffirmed its annual net sales forecast despite a quarterly rise, citing weak North America demand. In the quarter ended June 30, net sales rose 4.9% to $5.36 billion and adjusted EPS was 99 cents. North America organic sales fell 3%, with volumes down 3.9%. The company expects 2026 adjusted earnings growth in mid-single digits and warned tariffs could offset refunds.

$CLMed

Colgate-Palmolive: Base Business EPS Increases 8% As Gross Margin Expands 140 Basis Points

Colgate-Palmolive reported Q2 2026 Base Business diluted EPS up 8% to $0.99 from $0.92, driven by 140 bps gross-margin expansion to 61.5% and higher organic sales. Reported diluted EPS fell 5% to $0.86 due to $129m pretax charges tied to its Strategic Growth and Productivity Program. Net sales rose 4.9% to $5.36b. Full-year organic outlook 1% to 4%; Base Business EPS expected mid-single-digit growth.

$CLMed

Colgate-Palmolive Q2 Earnings Call Highlights

Colgate-Palmolive (NYSE:CL) CFO Stan Sutula said Q2 material costs were slightly below expectations due to higher raw-material costs offset by tariff refunds, with no meaningful additional refunds expected. Management now expects full-year gross margin roughly flat, and warned second-half raw-material and tariff costs will be higher. It plans elevated ad spending and North America share recovery; Hill’s organic sales rose 4% excluding discontinued private-label.

$CLHighAI 9/10

Colgate-Palmolive Q2 2026 slides: strong results fuel raised guidance

Colgate-Palmolive (NYSE:CL) reported Q2 2026 results on July 31. Net sales rose 4.9% to $5.36B and organic sales grew 2.4%. Base EPS increased 8% and free cash flow rose 18% YoY to $1.5B YTD. The company raised 2026 guidance, including flat gross margin outlook and higher EPS growth, and projected $350M to $550M pre-tax charges for its 2030 program.

$CLMed

Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down

Colgate-Palmolive reported Q2 net earnings of $693 million, down from $743 million a year earlier, with EPS falling to $0.86 from $0.91. Net sales rose to $5.361 billion. The company confirmed FY2026 outlook and raised Base Business EPS growth to mid-single-digit from low- to mid-single-digit, and expects gross margin roughly flat. Shares were down about 2.78% premarket.